Skip to content

To Evaluate fasting serum uric acid levels in patients of bipolar type 1 disorder

Evaluation of serum uric acid levels in bipolar type 1 disorder patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072235
Enrollment
100
Registered
2024-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F31- Bipolar disorder

Interventions

Intervention1: NIL: NIL

Sponsors

Government Medical College And Hospital, Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfilling the criteria for Bipolar type 1 disorder, current episode manic with or without psychotic symptoms, as per ICD 11. 2. Current Young Mania Rating Scale score greater than 7. 3. Treatment naive patients or off treatment with mood stabilisers/antipsychotics since 2 months.

Exclusion criteria

Exclusion criteria: 1. History of any comorbid Psychiatric disorder. 2. History of any medical condition that would affect uric acid metabolism such as cerebrovascular disease, organic brain disease, inflammatory disease, chronic kidney disease, gout, disorders of lipid metabolism etc. 3. History of consumption of alcohol or any other psychoactive substance in the past one month(excluding nicotine and caffeine) 4. Violent or uncooperative patients. 5. On medication such as allopurinol which alter serum uric acid concentration. 6. History of use of long acting antipsychotics in the past 6 months. 7. History of electroconvulsive therapy administration in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Assess and compare serum uric acid levels in patients of Bipolar type 1 disorder, currently in manic phase once at baseline and then after 8 weeks of treatment.Timepoint: Baseline, 8 weeks.

Secondary

MeasureTime frame
The serum uric acid levels at baseline will be correlated with severity of the manic episode as assesed on Young Mania Rating Scale(YMRS).Timepoint: Baseline, 8 weeks;The changes in serum uric acid levels will be correlated in treatment responsders and non responders. Responders would classify as bipolar type 1 patients, currently in manic phase with YMRS scores after 8 weeks of treatment as less than 7.Timepoint: Baseline, 8 weeks

Countries

India

Contacts

Public ContactDr Vijay Goswami

Government Medical College and Hospital, Sector 32, Chandigarh

drpritiarun@gmail.com9646121612

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026